Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud E S Soliman

Showing results (1-10 of 224) with videos related to

Pageof 23
Sort By:
Journal of Biomolecular Structure & Dynamics|March 30, 2017
Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discoveryPritika Ramharack, Mahmoud E S Soliman
Cell Biochemistry and Biophysics|February 2, 2017
VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular DynamicsMarissa Balmith, Mahmoud E S Soliman
Combinatorial Chemistry & High Throughput Screening|March 10, 2015
In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulationsMbatha Sbongile, Mahmoud E S Soliman
Chemical Biology & Drug Design|June 21, 2018
A panoptic uncovering of the dynamical evolution of the Zika Virus NS5 methyltransferase binding site loops-zeroing in on the molecular landscapeNikita Devnarain, Mahmoud E S Soliman
Journal of Receptor and Signal Transduction Research|October 9, 2015
A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entryEmiliene Berinyuy, Mahmoud E S Soliman
Interdisciplinary Sciences, Computational Life Sciences|May 12, 2016
Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modellingEmiliene Berinyuy, Mahmoud E S Soliman
Current Pharmaceutical Biotechnology|October 28, 2020
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 TreatmentClement Agoni, Mahmoud E S Soliman
Molecular Biosystems|February 8, 2017
Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virusMarissa Balmith, Mahmoud E S Soliman
The Protein Journal|October 6, 2019
Unveiling a New Era in Malaria Therapeutics: A Tailored Molecular Approach Towards the Design of Plasmepsin IX InhibitorsGeraldene Munsamy, Mahmoud E S Soliman
Chemical Biology & Drug Design|April 26, 2013
Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulationsYushir Maharaj, Mahmoud E S Soliman
Pageof 23

Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
Journal of Biomolecular Structure & Dynamics|March 30, 2017
Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discoveryPritika Ramharack, Mahmoud E S Soliman
Cell Biochemistry and Biophysics|February 2, 2017
VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular DynamicsMarissa Balmith, Mahmoud E S Soliman
Combinatorial Chemistry & High Throughput Screening|March 10, 2015
In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulationsMbatha Sbongile, Mahmoud E S Soliman
Chemical Biology & Drug Design|June 21, 2018
A panoptic uncovering of the dynamical evolution of the Zika Virus NS5 methyltransferase binding site loops-zeroing in on the molecular landscapeNikita Devnarain, Mahmoud E S Soliman
Journal of Receptor and Signal Transduction Research|October 9, 2015
A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entryEmiliene Berinyuy, Mahmoud E S Soliman
Interdisciplinary Sciences, Computational Life Sciences|May 12, 2016
Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modellingEmiliene Berinyuy, Mahmoud E S Soliman
Current Pharmaceutical Biotechnology|October 28, 2020
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 TreatmentClement Agoni, Mahmoud E S Soliman
Molecular Biosystems|February 8, 2017
Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virusMarissa Balmith, Mahmoud E S Soliman
The Protein Journal|October 6, 2019
Unveiling a New Era in Malaria Therapeutics: A Tailored Molecular Approach Towards the Design of Plasmepsin IX InhibitorsGeraldene Munsamy, Mahmoud E S Soliman
Chemical Biology & Drug Design|April 26, 2013
Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulationsYushir Maharaj, Mahmoud E S Soliman
Pageof 23